Umoja Biopharma

Series-B+
umoja-biopharma.com Biotech & Healthcare Seattle, United States Founded 2019 51-100
Total Funding $363M
Latest Round $100M Series-B+
Last Announced Jan 14, 2025
Investors 15 Backers
Decision Makers 6 Verified

About Umoja Biopharma

Umoja Biopharma develops in vivo CAR T cell therapies for patients with cancer. The company's VivoVec platform generates CAR T cells directly in a patient's body. Umoja Biopharma manufactures its lentiviral products in-house.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Seattle, United States
Year Founded 2019
Team Size 51-100
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website umoja-biopharma.com
Domain Registered Date May 19, 2019

Social & Network Presence

X / Twitter Profile @UmojaBiopharma (318 followers) Created on Jul 2020
LinkedIn Corporate Not linked

Company Milestones & Timeline

6 Events
  1. Capital Raise

    Raised $100,000,000 · Series-B+

    startupintros.com

  2. Capital Raise

    Raised $210,000,000 · Series-B+

  3. Capital Raise

    Raised $53,000,000 · Series-A

    startupintros.com

  4. Milestone

    X account created (@UmojaBiopharma)

    318 followers

  5. Milestone

    Website domain registered

    umoja-biopharma.com

  6. Milestone

    Company founded

    Seattle, United States

Investors & Backers

15
ARK Investment Management
CaaS Capital Management
Cormorant Asset Management
DCVC Bio
Double Point Ventures
Emerson Collective
K2 HealthVentures
MPM Capital
Myeloma Investment Fund
Presight Capital
Qiming Venture Partners USA
RTW Investments
SoftBank Vision Fund
SVB Securities
Temasek

Funding History

3 Rounds
Series-B+ · Jan 14, 2025
$100,000,000 startupintros.com
Series-B+ · Jun 15, 2021
$210,000,000 Source
Series-A · Nov 1, 2020

Founders & Leadership

5

Andrew Scharenberg

Founder

Work email & phone locked Unlock →

David Fontana

Chief Operating Officer

Work email & phone locked Unlock →

Philip Low

Founder

Work email & phone locked Unlock →

Ryan Crisman

Founder

Work email & phone locked Unlock →

Tim Gardner

Executive Vice President-Strategy and Business Development

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts